INIS
patients
100%
arthritis
83%
juveniles
55%
children
36%
diseases
33%
recommendations
21%
tumor necrosis factor
21%
blocking
20%
learning
19%
education
19%
pain
17%
glucocorticoids
17%
assessments
16%
management
15%
medicine
13%
teaching
13%
data
12%
comparative evaluations
11%
drugs
11%
range
10%
information
9%
feedback
9%
interventions
8%
pediatrics
8%
reviews
8%
cost
7%
investigations
7%
therapy
7%
adolescents
6%
adults
6%
Keyphrases
Systemic Juvenile Idiopathic Arthritis (sJIA)
50%
Etanercept
43%
Dutch
42%
Arthritis
41%
Professionalism
25%
Biological Agents
20%
Blocking Agent
20%
Rheumatoid Arthritis
20%
Tumor Necrosis Factor-α
20%
EULAR Recommendations
20%
Inactive Disease
14%
Intensive Care Medicine
13%
Spondyloarthritis
13%
General Practitioners
13%
Adalimumab
13%
Rheumatoid Arthritis Treatment
13%
Medical Students
13%
Axial Spondyloarthritis (AxSpA)
12%
Everyday Practices
11%
Systematic Literature Review
11%
Unprofessional Behaviour
10%
Clinical Response
9%
Rheumatologists
9%
Treatment Efficacy
9%
Synthetic Disease-modifying Antirheumatic Drugs
8%
Medical Residents
8%
Social Media
8%
Literature Search
8%
Educational Intervention
7%
Professional Activity
7%